MARKET

ACHV

ACHV

Achieve
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3125
-0.0061
-1.91%
After Hours: 0.3230 +0.0105 +3.36% 16:38 04/02 EDT
OPEN
0.3200
PREV CLOSE
0.3186
HIGH
0.3300
LOW
0.3125
VOLUME
354.55K
TURNOVER
--
52 WEEK HIGH
4.630
52 WEEK LOW
0.2257
MARKET CAP
9.80M
P/E (TTM)
-0.1469
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ACHV stock price target is 4.667 with a high estimate of 10.00 and a low estimate of 2.000.

EPS

ACHV News

More
  • Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics
  • GlobeNewswire · 12h ago
  • Achieve Life Sciences EPS beats by $0.02
  • seekingalpha · 03/13 17:02
  • Achieve Life Sciences, Inc.'s (ACHV) CEO Richard Stewart on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/13 16:31
  • Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
  • CNW Group · 03/13 13:00

Industry

Biotechnology & Medical Research
+3.32%
Pharmaceuticals & Medical Research
+2.80%

Hot Stocks

Symbol
Price
%Change

About ACHV

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually worldwide. Cytisine is an established 25 day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by a third party for over 20 years under the brand name TabexTM. As of December 2016, it is estimated that over 21 million people have used cytisine to help combat nicotine addiction, including over 2,000 patients in investigator-conducted, Phase III clinical trials in Europe and New Zealand.
More

Webull offers kinds of Achieve Life Sciences Inc stock information, including NASDAQ:ACHV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACHV stock news, and many more online research tools to help you make informed decisions.